VRDN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Viridian Therapeutics (VRDN) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VRDN is expected to report earnings to fall 10.43% to -102 cents per share on February 26

Viridian Therapeutics VRDN Stock Earnings Reports

Q4'24

Est.

$-1.03

Q3'24

Missed

by $0.09

Q2'24

Missed

by $0.15

Q1'24

Beat

by $0.30

Q4'23

Missed

by $0.37

The last earnings report on November 12 showed earnings per share of -114 cents, missing the estimate of -105 cents. With 493.87K shares outstanding, the current market capitalization sits at 1.35B.

View a ticker or compare two or three

Compare

VRDN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VRDN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VRDN (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

221 Crescent Street

Phone

+1 617 272-4600

Employees

Web

https://www.viridiantherapeutics.com